Gao et al. exhibited that miR-29a exerts inhibitory effect on HCC progression by down-regulating histone lysine N methyltransferase 5C (KMT5C), which acts as an HCC biomarker and prognostic indicator and functions as an HCC oncogene [52]. This evidence concerns the gene KMT5C and hepatocellular carcinoma.